KLRG1 and cancer: Importantly, inhibiting KLRG1/AMPK signaling can prevent AMPK activation and reinstate NK cell cytotoxicity, cytokine secretion, proliferation, and telomerase expression, thereby bolstering immunity in aging individuals and in individuals with malignant tumors [10, 42].